Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

Beatriz Grinsztejn, Bach-Yen Nguyen, Christine Katlama, José M. Gatell, Adriano Lazzarin, Daniel Vittecoq, Charles J. Gonzalez, Joshua Chen, Charlotte M. Harvey, Robin Isaacs

The Lancet · 2007 · 568 citations · 12 references

DOIFull text

Open access

Concepts

References

12